Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion type Assertion NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_head.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion wasGeneratedBy ECO_0000203 NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_provenance.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion wasDerivedFrom lhgdn-20090331 NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_provenance.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion SIO_000772 17145811 NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_provenance.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion evidence source_evidence_literature NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_provenance.
- NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_assertion description "[The MAL2 gene was shown to effectively separate these two tumor (chromophobe renal cell carcinoma (RCC) and benign oncocytoma) groups by quantitative reverse transcription-PCR using fresh tissue samples, with similar trends seen on formalin-fixed tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112525.RADlZJinBGjKo8IsXVOF1jwjkvYaEyBfV3gPYGAAShgRM130_provenance.